Structural and functional diversity of adaptor proteins involved in tyrosine kinase signalling

BioEssays

Volumn 28, Issue 5, 2006, Pages 465-479

  Csiszá, Ágnes ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PLECKSTRIN; PROTEIN SH3; PROTEIN TYROSINE KINASE;

PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BINDING SITES; CASPASES; CELL COMPARTMENTATION; DIMERIZATION; HUMANS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 33646358721     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20411     Document Type: Review

References (102)

1. Sawasdikosol S, Pratt JC, Meng W, Eck MJ, Burakoff SJ. 2000. Adapting to multiple personalities: Cbl is also a RING finger ubiquitin ligase. Biochim Biophys Acta 1471:M1-M12.
2. Schlessinger J, Lemmon MA. 2003. SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003 (191):RE12.
3. Uhlik MT, Temple B, Bencharit S, Kimple AJ, Siderovski DP, et al. 2005. Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J Mol Biol 345:1-20.
4. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
5. Benes CH, Wu N, Elia AE, Dharia T, Cantley LC, et al. 2005. The C2 domain of PKCdelta is a phosphotyrosine binding domain. Cell 121:271-280.
6. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, et al. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76:933-945.
7. Mayer BJ. 2001. SH3 domains: complexity in moderation. J Cell Sci 114:1253-1263.
8. Lemmon MA, Ferguson KM. 2000. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J 350:1-18.
9. O'Bryan JP, Martin CB, Songyang Z, Cantley LC, Der CJ. 1996. Binding specificity and mutational analysis of the phosphotyrosine binding domain of the brain-specific adaptor protein ShcC. J Biol Chem 271:11787-11791.
10. Dente L, Vetriani C, Zucconi A, Pelicci G, Lanfrancone L, et al. 1997. Modified phage peptide libraries as a tool to study specificity of phosphorylation and recognition of tyrosine containing peptides. J Mol Biol 269:694-703.
11. Stolt PC, Vardar D, Blacklow SC. 2004. The dual-function disabled-1 PTB domain exhibits site independence in binding phosphoinositide and peptide ligands. Biochemistry 43:10979-10987.
12. Sadowski I, Stone JC, Pawson T. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 6:4396-4408.
13. Yaffe MB. 2002. Phosphotyrosine-binding domains in signal transduction. Nat Rev Mol Cell Biol 3:177-186.
14. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, et al. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14:2777-2785.
15. Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ. 1999. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398:84-90
16. Yokoyama K, Su IH, Tezuka T, Yasuda T, Mikoshiba K, et al. 2002. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. Embo J 21:83-92.
17. Newton AC, Johnson JE. 1998. Protein kinase C: a paradigm for regulation of protein function by two membrane-targeting modules. Biochim Biophys Acta 1376:155-172.
18. Mayer BJ, Eck MJ. 1995. SH3 domains. Minding your p's and q's. Curr Biol 5:364-367.
19. Cozier GE, Carlton J, Bouyoucef D, Cullen PJ. 2004. Membrane targeting by pleckstrin homology domains. Curr Top Microbiol Immunol 282:49-88.
20. Kioka N, Ueda K, Amachi T. 2002. Vinexin, CAP/ponsin, ArgBP2: a novel adaptor protein family regulating cytoskeletal organization and signal transduction. Cell Struct Funct 27:1-7.
21. Simeoni L, Kliche S, Lindquist J, Schraven B. 2004. Adaptors and linkers in T and B cells. Current Opinion in Immunology 16:304-313.
22. Greene TA, Powell P, Nzerem C, Shapiro MJ, Shapiro VS. 2003. Cloning and characterization of ALX, an adaptor downstream of CD28. J Biol Chem 278:45128-45134.
23. Han DC, Shen TL, Guan JL. 2001. The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20:6315-6321.
24. Lu Y, Brush J, Stewart TA. 1999. NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway. J Biol Chem 274:10047-10052.
25. Sakakibara A, Hattori S. 2000. Chat, a Cas/HEF1-associated adaptor protein that integrates multiple signaling pathways. J Biol Chem 275:6404-6410.
26. Kubo M, Hanada T, Yoshimura A. 2003. Suppressors of cytokine signaling and immunity. Nat Immunol 4:1169-1176.
27. Ahn MY, Katsanakis KD, Bheda F, Pillay TS. 2004. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J Biol Chem 279:21526-21532.
28. Iseki M, Kubo-Akashi C, Kwon SM, Yamaguchi A, Takatsu K, et al. 2005. APS, an adaptor molecule containing PH and SH2 domains, has a negative regulatory role in B cell proliferation. Biochem Biophys Res Commun 330:1005-1013.
29. Niiro H, Allam A, Stoddart A, Brodsky FM, Marshall AJ, et al. 2004. The B lymphocyte adaptor molecule of 32 kilodaltons (Bam32) regulates B cell antigen receptor internalization. J Immunol 173:5601-5609.
30. Feller SM. 2001. Crk family adaptors-signalling complex formation and biological roles. Oncogene 20:6348-6371.
31. Liu SK, Berry DM, McGlade CJ. 2001. The role of Gads in hematopoietic cell signalling. Oncogene 20:6284-6290.
32. Tari AM, Lopez-Berestein G. 2001. GRB2: a pivotal protein in signal transduction. Semin Oncol 28:142-147.
33. McCarty JH. 1998. The Nek SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events. Bioessays 20:913-921.
34. Davis MM. 2002. A new trigger for T cells. Cell 110:285-287.
35. Sosinowski T, Pandey A, Dixit VM, Weiss A. 2000. Src-like adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. J Exp Med 191:463-474.
36. Luzi L, Confalonieri S, Di Fiore PP, Pelicci PG. 2000. Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 10:668-674.
37. Ravichandran KS. 2001. Signaling via Shc family adapter proteins. Oncogene 20:6322-6330.
38. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, et al. 2001. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol 21:4177-4187.
39. Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, et al. 2000. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol Cell Biol 20:979-989.
40. Le N, Simon MA. 1998. Disabled is a putative adaptor protein that functions during signaling by the sevenless receptor tyrosine kinase. Mol Cell Biol 18:4844-4854.
41. Schmid RS, Jo R, Shelton S, Kreidberg JA, Anton ES. 2005. Reelin, Integrin and Dab1 Interactions during Embryonic Cerebral Cortical Development. Cereb Cortex.
42. Abramson J, Rozenblum G, Pecht I. 2003. Dok protein family members are involved in signaling mediated by the type 1 Fcepsilon receptor. Eur J Immunol 33:85-91.
43. Johnston AM, Pirola L, Van Obberghen E. 2003. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett 546:32-36.
44. Shpakov AO, Pertseva MN. 2000. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins. Membr Cell Biol 13:455-484.
45. Offenhauser N, Borgonovo A, Disanza A, Romano P, Ponzanelli I, et al. 2004. The eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. Mol Biol Cell 15:91-98.
46. Baisden JM, Qian Y, Zot HM, Flynn DC. 2001. The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity. Oncogene 20:6435-6447.
47. Baisden JM, Gatesman AS, Cherezova L, Jiang BH, Flynn DC. 2001. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene 20:6607-6616.
48. Nishida K, Hirano T. 2003. The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci 94:1029-1033.
49. Kurosaki T. 2002. Regulation of B-cell signal transduction by adaptor proteins. Nat Rev Immunol 2:354-363.
50. Bouton AH, Riggins RB, BruceStaskal PJ. 2001. Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 20:6448-6458.
51. Dikic I. 2002. CIN85/CMS family of adaptor molecules. FEBS Lett 529:110-115.
52. Daly RJ. 2004. Cortactin signalling and dynamic actin networks. Biochem J 382:13-25.
53. Ichigotani Y, Fujii K, Hamaguchi M, Matsuda S. 2002. In search of a function for the E3B1/Abi2/Argbp1/NESH family (Review). Int J Mol Med 9:591-595.
54. Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T. 2000. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13:817-827.
55. Wilson R, Battersby A, Csiszar A, Vogelsang E, Leptin M. 2004. A functional domain of Dof that is required for fibroblast growth factor signaling. Mol Cell Biol 24:2263-2276.
56. Petit V, Nussbaumer U, Dossenbach C, Affolter M. 2004. Downstream-of-FGFR is a fibroblast growth factor-specific scaffolding protein and recruits Corkscrew upon receptor activation. Mol Cell Biol 24:3769-3781.
57. Schaller MD. 2001. Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20:6459-6472.
58. Horejsi V, Zhang W, Schraven B. 2004. Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat Rev Immunol 4:603-616.
59. Jones N, Dumont DJ. 1999. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation. Curr Biol 9:1057-1060.
60. Van Slyke P, Coll ML, Master Z, Kim H, Filmus J, et al. 2005. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk. Mol Cell Biol 25:3831-3841.
61. Dikic I, Giordano S. 2003. Negative receptor signalling. Curr Opin Cell Biol 15:128-135.
62. Hoeller D, Volarevic S, Dikic I. 2005. Compartmentalization of growth factor receptor signalling. Curr Opin Cell Biol 17:107-111.
63. Szymkiewicz I, Shupliakov O, Dikic I. 2004. Cargo- and compartment-selective endocytic scaffold proteins. Biochem J 383:1-11.
64. Pawson T. 1995. Protein modules and signalling networks. Nature 373:573-580.
65. Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J, et al. 2001. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc Natl Acad Sci USA 98:6074-6079.
66. Lock LS, Royal I, Naujokas MA, Park M. 2000. Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J Biol Chem 275:31536-31545.
67. Rajala RV, Chan MD. 2005. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1. Biochemistry 44:7929-7935.
68. Wilkinson B, Wang H, Rudd CE. 2004. Positive and negative adaptors in T-cell signalling. Immunology 111:368-374.
69. Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31-39.
70. Douglass AD, Vale RD. 2005. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 121:937-950.
71. Holler D, Dikic I. 2004. Receptor endocytosis via ubiquitin-dependent and -independent pathways. Biochem Pharmacol 67:1013-1017.
72. Yamada S, Taketomi T, Yoshimura A. 2004. Model analysis of difference between EGF pathway and FGF pathway. Biochem Biophys Res Commun 314:1113-1120.
73. Levchenko A, Bruck J, Sternberg PW. 2000. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc Natl Acad Sci USA 97:5818-5823.
74. Lax I, Wong A, Lamothe B, Lee A, Frost A, et al. 2002. The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol Cell 10:709-719.
75. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS. 2004. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 24:5269-5280.
76. Wu Y, Chen Z, Ullrich A. 2003. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2. Biol Chem 384:1215-1226.
77. Ong SH, Lim YP, Low BC, Guy GR. 1997. SHP2 associates directly with tyrosine phosphorylated p90 (SNT) protein in FGF-stimulated cells. Biochem Biophys Res Commun 238:261-266.
78. Campbell DH, Sutherland RL, Daly RJ. 1999. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 59:5376-5385.
79. Lehr S, Kotzka J, Avci H, Sickmann A, Meyer HE, et al. 2004. Identification of major ERK-related phosphorylation sites in Gab1. Biochemistry 43:12133-12140.
80. Huang C, Borchers CH, Schaller MD, Jacobson K 2004. Phosphorylation of paxillin by p38MAPK is involved in the neurite extension of PC-12 cells. J Cell Biol 164:593-602.
81. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K. 2003. JNK phosphorylates paxillin and regulates cell migration. Nature 424:219-223.
82. Songyang Z, Yamanashi Y, Liu D, Baltimore D. 2001. Domain-dependent function of the rasGAP-binding protein p62Dok in cell signaling. J Biol Chem 276:2459-2465.
83. Qian Y, Gatesman AS, Baisden JM, Zot HG, Cherezova L, et al 2004. Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110 to alter actin filament integrity. J Cell Biochem 91:602-620.
84. Qian Y, Baisden JM, Cherezova L, Summy JM, Guappone-Koay A, et al. 2002. PC phosphorylation increases the ability of AFAP-110 to crosslink actin filaments. Mol Biol Cell 13:2311-2322.
85. Dong LQ, Porter S, Hu D, Liu F. 1998. Inhibition of hGrb10 binding to the insulin receptor by functional domain-mediated oligomerization. J Biol Chem 273:17720-1775.
86. Liu F, Roth RA. 1998. Binding of SH2 containing proteins to the insulin receptor: a new way for modulating insulin signalling. Mol Cell Biochem 182:73-78.
87. Law SF, Zhang YZ, Fashena SJ, Toby G, Estojak J, et al. 1999. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain. Exp Cell Res 252:224-235.
88. Battersby A, Csiszar A, Leptin M, Wilson R. 2003. Isolation of proteins that interact with the signal transduction molecule Dof and identification of a functional domain conserved between Dof and vertebrate BCAP. J Mol Biol 329:479-493.
89. Law SF, Zhang YZ, Klein-Szanto AJ, Golemis EA. 1998. Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments. Mol Cell Biol 18:3540-3551.
90. Law SF, O'Neill GM, Fashena SJ, Einarson MB, Golemis EA. 2000. The docking protein HEF1is an apoptotic mediator at focal adhesion sites. Mol Cell Biol 20:5184-5195.
91. Bannerman DD, Sathyamoorthy M, Goldblum SE. 1998. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J Biol Chem 273:35371-35380.
92. Berry DM, Benn SJ, Cheng AM, McGlade CJ. 2001. Caspase-dependent cleavage of the hematopoietic specific adaptor protein Gads alters signalling from the T cell receptor. Oncogene 20:1203-1211.
93. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. 1999. Caspase activation is required for T cell proliferation. J Exp Med 190:1891-1896.
94. Wong A, Lamothe B, Lee A, Schlessinger J, Lax I, et al. 2002. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci USA 99:6684-6689.
95. Kamura T, Sato S, Haque D, Liu L, Kaelin WG Jr, et al. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12:3872-3881.
96. Johnson ES. 2004. Protein modification by SUMO. Annu Rev Biochem 73:355-382.
97. Sobko A, Ma H, Firtel RA. 2002. Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev Cell 2:745-756.
98. Kamemura K, Hart GW. 2003. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. Prog Nucleic Acid Res Mol Biol 73:107-136.
99. Whelan SA, Hart GW. 2003. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res 93:1047-1058.
100. Su IH, Dobenecker MW, Dickinson E, Oser M, Basavaraj A, et al. 2005. Polycomb group protein Ezh2 controls actin polymerization andcell signaling. Cell 121:425-436.
101. Yang XJ. 2004. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26:1076-1087.
102. Mumby M. 2001. A new role for protein methylation: switching partners at the phosphatase ball. Sci STKE 2001 (79):PE1.